Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82,051,282
-
Number of holders
-
76
-
Total 13F shares, excl. options
-
28,247,430
-
Shares change
-
+3,395,736
-
Total reported value, excl. options
-
$326,826,712
-
Value change
-
+$27,411,391
-
Number of buys
-
49
-
Number of sells
-
34
-
Price
-
$11.57
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q2 2022
As of 30 Jun 2022 Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) had 76 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,247,430 shares of stock of the company.
Largest 10 holders included VR Adviser, LLC, BVF INC/IL, COMMODORE CAPITAL LP, BlackRock Inc., VANGUARD GROUP INC, TCG Crossover Management, LLC, Paradigm Biocapital Advisors LP, Vivo Capital, LLC, Deep Track Capital, LP, and MILLENNIUM MANAGEMENT LLC.
This table shows 76 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.